Related Experiment Video

Updated: Jul 17, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Update in the treatment of brain metastases from lung cancer

Amanda L Schwer1, Laurie E Gaspar

  • 1University of Colorado Health Sciences Center, Aurora, CO 80010, USA.

Clinical Lung Cancer
|January 24, 2007
PubMed

Insights

Brain metastases are a common challenge in lung cancer, with poor survival rates despite research advances. This review highlights clinical features, prognostic factors, and treatments for lung cancer brain metastases, emphasizing recent developments.

Area of Science:

  • Oncology
  • Neurology
  • Medical Research

Background:

  • Brain metastases are a frequent complication of both non-small-cell lung cancer and small-cell lung cancer.
  • The brain is a common site for isolated disease recurrence in lung cancer patients.
  • Despite advancements, survival outcomes for lung cancer with brain metastases remain unsatisfactory.

Purpose of the Study:

  • To review the clinical characteristics of lung cancer brain metastases.
  • To identify prognostic factors influencing patient outcomes.
  • To discuss current and emerging treatment strategies, focusing on recent research.

Main Methods:

  • Literature review of clinical studies and research developments.
  • Analysis of clinical characteristics and prognostic indicators.
  • Synthesis of information on treatment modalities for lung cancer brain metastases.

Main Results:

  • Lung cancer brain metastases present unique clinical features and outcomes compared to metastases from other primary sites.
  • Prognostic factors require careful consideration for tailored treatment approaches.
  • Recent research offers new insights into managing this complex condition.

Conclusions:

  • Lung cancer brain metastases necessitate distinct clinical and therapeutic strategies.
  • Further research is crucial to improve survival rates and patient management.
  • Personalized treatment approaches based on specific characteristics are essential.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...